A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma
Titel:
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma
Auteur:
Jermann, Monika Stahel, Rolf A Salzberg, Marc Cerny, Thomas Joerger, Markus Gillessen, Silke Morant, Rudolf Egli, Fritz Rhyner, Kaspar Bauer, Jean A Pless, Miklos